Research Shows mNGS Speeds Diagnosis

New research shows Delve Detect reduces testing burden for meningitis/encephalitis by over 60% and delivers diagnoses a week earlier, enabling faster, targeted care.

Featured Publication

Evaluating the Clinical Impact of Metagenomic Next-Generation Sequencing in CNS Infections: A Diagnostic Pathway and Resource Utilization Modeling Study

In an infectious cohort, nearly 64% of microbiological tests were avoidable, reducing time to diagnosis by almost 7 days per patient. The effect was even more pronounced in autoimmune encephalitis, where 92% of tests were unnecessary—cutting diagnosis time by more than 10 days per patient. See how early use of mNGS could impact your patients and institution utilizing our cost calculator below.

How can Delve Detect reduce your testing burden?

Calculate the impact of early use of mNGS for individual patients and your institution based on the study’s findings.

Suspected Diagnosis
Calculation Mode

Approximate cases per month

Microbiological Tests Avoided
Clinical Impact of mNGS on Tests and Length of Stay

Tests avoided

0.0

Days to diagnosis saved

0.0

Lumbar Punctures Avoided

Per month

0.0

Per year

0.0

Based on 10 patients

Want a custom analysis for your institution?